JOP20190286A1 - Compositions and methods for treating tauopathies - Google Patents

Compositions and methods for treating tauopathies

Info

Publication number
JOP20190286A1
JOP20190286A1 JOP/2019/0286A JOP20190286A JOP20190286A1 JO P20190286 A1 JOP20190286 A1 JO P20190286A1 JO P20190286 A JOP20190286 A JO P20190286A JO P20190286 A1 JOP20190286 A1 JO P20190286A1
Authority
JO
Jordan
Prior art keywords
compositions
methods
tauopathies
treating tauopathies
formulations
Prior art date
Application number
JOP/2019/0286A
Other languages
Arabic (ar)
Inventor
Yong Quan
Giridhar Tirucherai
Lori S Burton
Masano Tlaneci Huang
Michael Frans Burgess
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to JOP/2019/0286A priority Critical patent/JOP20190286A1/en
Publication of JOP20190286A1 publication Critical patent/JOP20190286A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies such as progressive supranuclear palsy and Alzheimer's disease. Fig. 8
JOP/2019/0286A 2018-12-16 2018-12-16 Compositions and methods for treating tauopathies JOP20190286A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2019/0286A JOP20190286A1 (en) 2018-12-16 2018-12-16 Compositions and methods for treating tauopathies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2019/0286A JOP20190286A1 (en) 2018-12-16 2018-12-16 Compositions and methods for treating tauopathies

Publications (1)

Publication Number Publication Date
JOP20190286A1 true JOP20190286A1 (en) 2019-12-15

Family

ID=75438427

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2019/0286A JOP20190286A1 (en) 2018-12-16 2018-12-16 Compositions and methods for treating tauopathies

Country Status (1)

Country Link
JO (1) JOP20190286A1 (en)

Similar Documents

Publication Publication Date Title
MX2019015071A (en) Compositions and methods for treating tauopathies.
PH12020500500A1 (en) Pyrazolopyrimidinone compounds and uses thereof
MA51796A (en) METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF THERAPEUTIC PROTEINS
SA519400950B1 (en) Compositions and Methods of Inhibiting MASP-3 for The Treatment of Various Diseases and Disorders
MX2019007587A (en) Ophthalmic composition for treatment of dry eye disease.
MX2019007480A (en) Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation.
CY1122265T1 (en) ANTIBODIES AGAINST THEM AND THEIR USES
JOP20190146A1 (en) Amino acid compositions and methods for the treatment of liver diseases
MA47313B1 (en) Her2 antibody subcutaneous formulations
MX2019005594A (en) Agents, uses and methods for the treatment of synucleinopathy.
MY196631A (en) Antibody Agents Specific for Human Cd19 and uses Thereof
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
JOP20190147A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
EA201991029A1 (en) MAGL INHIBITORS
MX2021007392A (en) Dosing regimen and pharmaceutical combination comprising 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives.
MX2020014031A (en) Heterodimeric proteins and uses thereof.
MX2019003805A (en) Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies.
MX2021002916A (en) Deuterium-enriched pirfenidone and methods of use thereof.
MX2021004517A (en) Tricyclic janus kinase 1 inhibitors, and compositions and methods thereof.
MX2020009733A (en) Compositions.
MX2019006495A (en) Treatment of neurological diseases.
PH12020552235A1 (en) Anti-cd40 antibodies for use in treating autoimmune disease
MX2019001958A (en) Methods of treating crohn's disease with an anti-nkg2d antibody.
NZ762312A (en) Anti-pacap antibody
MX2021005248A (en) B-cell activating cd73 antibodies.